The melatonin receptor subtype MT2 is present in the human cardiovascular system

Area of Science:

• Cardiovascular Biology
• Molecular Cardiology
• Pharmacology

Background:

• Melatonin receptor subtype MT1 is found in human coronary arteries.
• Experimental animal studies suggest MT2 melatonin receptor subtype presence in vasculature.
• Melatonin influences myocyte function, necessitating investigation of MT2 in human ventricles.

Purpose of the Study:

• Investigate MT2 melatonin receptor subtype expression in human aorta and coronary arteries.
• Analyze MT2 expression in human ventricular specimens.
• Determine if MT2 expression differs in cardiomyopathy and coronary heart disease patients compared to controls.

Main Methods:

• Studied MT2 receptor expression in isolated human coronary arteries, aorta, and left ventricular specimens.
• Utilized reverse transcriptase (RT)-nested-polymerase chain reaction (PCR) for expression analysis.
• Included samples from healthy heart donors and patients with dilated or ischemic cardiomyopathy.

Main Results:

• MT2 receptor expression detected in all control specimens (aorta, left ventricle, coronary arteries).
• Visible MT2 receptor expression found in 12/15 cardiomyopathy and 10/15 coronary heart disease patients.
• Significant variation in MT2 receptor expression levels across aorta, left ventricle, and coronary arteries among individuals.

Conclusions:

• The MT2 receptor subtype is present in human arteries and left ventricles.
• MT2 receptor expression appears altered in coronary heart disease.
• Evidence suggests heterogeneous MT2 expression patterns in individual patients, particularly in cardiovascular disease states.